These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 7514832)
41. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
42. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report. Okano A; Hajiro K; Takakuwa H; Kobashi Y Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347 [TBL] [Abstract][Full Text] [Related]
43. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452 [TBL] [Abstract][Full Text] [Related]
45. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331 [TBL] [Abstract][Full Text] [Related]
46. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma. Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946 [TBL] [Abstract][Full Text] [Related]
47. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors. Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880 [TBL] [Abstract][Full Text] [Related]
48. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. Bialecki ES; Ezenekwe AM; Brunt EM; Collins BT; Ponder TB; Bieneman BK; Di Bisceglie AM Clin Gastroenterol Hepatol; 2006 Mar; 4(3):361-8. PubMed ID: 16527701 [TBL] [Abstract][Full Text] [Related]
49. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy. Farinola MA; Weir EG; Ali SZ Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986 [TBL] [Abstract][Full Text] [Related]
50. Fine needle aspiration of the liver. Pinto MM; Avila NA; Heller CI; Criscuolo EM Acta Cytol; 1988; 32(1):15-21. PubMed ID: 2827416 [TBL] [Abstract][Full Text] [Related]
51. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Ma CK; Zarbo RJ; Frierson HF; Lee MW Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185 [TBL] [Abstract][Full Text] [Related]
52. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies. Papotti M; Pacchioni D; Negro F; Bonino F; Bussolati G Mod Pathol; 1994 Apr; 7(3):271-5. PubMed ID: 8058698 [TBL] [Abstract][Full Text] [Related]
53. Hepatoblastoma. Report of a case with cytologic, histologic and ultrastructural findings. Cangiarella J; Greco MA; Waisman J Acta Cytol; 1994; 38(3):455-8. PubMed ID: 7514834 [TBL] [Abstract][Full Text] [Related]
54. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Peng YC; Chan CS; Chen GH Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187 [TBL] [Abstract][Full Text] [Related]
55. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674 [TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma. Cantaboni A; Sironi M; Taccagni GL; Ferrari AM Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060 [TBL] [Abstract][Full Text] [Related]
57. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632 [TBL] [Abstract][Full Text] [Related]
58. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260 [TBL] [Abstract][Full Text] [Related]
59. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Wang L; Vuolo M; Suhrland MJ; Schlesinger K Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018 [TBL] [Abstract][Full Text] [Related]
60. Fine needle aspiration cytology of neuroblastoma, including peripheral neuroectodermal tumor, with immunocytochemical and ultrastructural confirmation. Silverman JF; Dabbs DJ; Ganick DJ; Holbrook CT; Geisinger KR Acta Cytol; 1988; 32(3):367-76. PubMed ID: 3287819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]